Compare MNDY & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNDY | STVN |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | Israel | Italy |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 4.2B |
| IPO Year | 2021 | 2021 |
| Metric | MNDY | STVN |
|---|---|---|
| Price | $76.05 | $15.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 25 | 4 |
| Target Price | ★ $174.92 | $25.13 |
| AVG Volume (30 Days) | ★ 3.0M | 594.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.70 | $10.26 |
| Revenue Next Year | $16.48 | $10.02 |
| P/E Ratio | $34.38 | ★ $27.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.68 | $13.91 |
| 52 Week High | $316.98 | $28.00 |
| Indicator | MNDY | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 36.83 | 43.75 |
| Support Level | $68.80 | $14.03 |
| Resistance Level | $79.30 | $17.14 |
| Average True Range (ATR) | 4.09 | 0.88 |
| MACD | 2.68 | 0.09 |
| Stochastic Oscillator | 53.26 | 30.33 |
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.